Skip to Content

Griseofulvin Oral Presentations

Last Updated: August 6, 2020
Status: Resolved

Products Affected - Description
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 500 mg, bottle, 30 count, NDC 64980-0186-03 - discontinued
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 500 mg, bottle, 100 count, NDC 64980-0186-01 - discontinued
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 125 mg, bottle, 30 count, NDC 64980-0184-03 - discontinued
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 125 mg, bottle, 100 count, NDC 64980-0184-01 - discontinued
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 250 mg, bottle, 30 count, NDC 64980-0185-03 - discontinued
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 250 mg, bottle, 100 count, NDC 64980-0185-01 - discontinued
Reason for the Shortage
    • Amneal has griseofulvin tablets available.
    • Cipla has griseofulvin suspension available.
    • Rising discontinued griseofulvin products.
    • Sandoz has griseofulvin tablets available.
    • Teva has griseofulvin suspension available.
Available Products
    • Griseofulvin oral suspension, Cipla USA, 125 mg/5 mL, 120 mL bottle, 1 count, NDC 69097-0361-08
    • Griseofulvin oral tablet, Sandoz, 500 mg, bottle, 100 count, NDC 00781-5515-01
    • Griseofulvin oral suspension, Teva, 125 mg/5 mL, 120 mL bottle, 1 count, NDC 00472-0013-04
    • Griseofulvin oral tablet, Amneal, 125 mg, bottle, 100 count, NDC 00115-1724-01

Updated

Updated August 6, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created July 18, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.